Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.33 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.33 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.33 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11980108 | 0.89 | NFE2L2 (0.41) | CA1CA2CA7CA9ACHE | |
| SCHEMBL776470 | 0.89 | NFE2L2 (0.41) | CA1CA2CA7CA9ACHE | |
| SCHEMBL3155473 | 0.87 | ACHE (0.62) | ACHENFE2L2 | |
| SCHEMBL7937426 | 0.87 | MAPT (0.41) | — | |
| SCHEMBL15910197 | 0.85 | HSPB1 (0.48) | MMP1MMP2MMP9MMP13 | |
| SCHEMBL28464325 | 0.85 | IDO1 (0.41) | IDO1LOXL2TAAR1 | |
| SCHEMBL19570743 | 0.85 | USP2 (0.42) | TAAR1 | |
| SCHEMBL7938378 | 0.83 | PAX8 (0.41) | ORAI1ORAI2ORAI3TRPV6CES2 | |
| SCHEMBL7938269 | 0.83 | TSHR (0.37) | — | |
| SCHEMBL7937373 | 0.83 | ALDH1A1 (0.39) | ACHENFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132782-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. | 2023-05-04 | — | — | US | claimed |
| EP-4121040-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | Global Biolife Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| WO-2021188520-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. (US) | 2021-09-23 | — | — | WO | claimed |
| CN-109081920-A | A kind of performed polymer containing sulfoxide structure and preparation method thereof and a kind of advanced composite material | 吉林大学 | 2018-12-25 | — | — | CN | claimed |
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | claimed |
| US-8034838-B2 | Composition and method for the treatment of neurological disorders | GLOBAL BIOLIFE, INC. | 2011-10-11 | — | — | US | claimed |
| US-20090298932-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | GLOBAL BIOLIFE, INC. | 2009-12-03 | — | — | US | claimed |
| JP-11269169-A | — | — | None | — | — | JP | disclosed |
| JP-8165290-A | — | — | None | — | — | JP | disclosed |
| CN-119504523-A | Preparation method of fluorine-containing phenyl sulfoxide compound | 苏州源起材料科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20230132782-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. | 2023-05-04 | — | — | US | disclosed |
| US-11609495-B2 | Radiation-sensitive resin composition and resist pattern-forming method | JSR CORPORATION (JP) | 2023-03-21 | — | — | US | disclosed |
| EP-0143407-B1 | PROCESS FOR PREPARING AROMATIC POLYETHERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-11-12 | — | — | EP | disclosed |
| EP-0067850-B1 | BLENDS OF COPOLY (ESTER-CARBONATE) WITH POLYSULFONE | GENERAL ELECTRIC COMPANY (US) | 1985-11-13 | — | — | EP | disclosed |
| EP-0143407-A2 | Process for preparing aromatic polyethers | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-06-05 | — | — | EP | disclosed |
| EP-0067850-A4 | BLENDS OF COPOLY (ESTER-CARBONATE) WITH POLYSULFONE. | GEN ELECTRIC (US) | 1983-04-18 | — | — | EP | disclosed |
| EP-0067850-A1 | BLENDS OF COPOLY (ESTER-CARBONATE) WITH POLYSULFONE. | GEN ELECTRIC (US) | 1982-12-29 | — | — | EP | disclosed |
| US-4358569-A | FLAME RESISTANT THERMOPLASTIC MOLDING MATERIAL OF GOOD IMPACT STRENGTH | GENERAL ELECTRIC COMPANY (US) | 1982-11-09 | — | — | US | disclosed |
| WO-1982002401-A1 | BLENDS OF COPOLYESTER-CARBONATE WITH POLYSULFONE | GEN ELECTRIC (US) | 1982-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230132782-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | ACE2, ACE, TMPRSS2 | CA1 2593/4885CA2 494/4885CA7 277/4885 |
| US-11609495-B2 | Radiation-sensitive resin composition and resist pattern-forming method | RER1, RAD51, AFF1 | CA1 1717/4885CA2 3709/4885CA7 2047/4885 |
| US-20090298932-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | BACE1, APP, BACE2 | CA1 1139/4885CA2 3585/4885CA7 4501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.